BioCryst Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 9.53 USD | 11,22 USD | 6 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 21 USD | 6 | 5 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 254.162.660 | 12,37 | 4,7 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name BioCryst Pharmaceuticals Inc
Mitarbeiter 435
Handelsplatz NASDAQ
Ticker Symbol BCRX
IPO Datum 1994-03-03
Adresse 4505 Emperor Boulevard, Durham, NC, United States, 27703
Webseite https://www.biocryst.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Charles K. Gayer | CEO, President & Director |
| 2 | Mr. Babar Ghias | CFO & Head of Corporate Development |
| 3 | Ms. Alane P. Barnes | Senior VP, Chief Legal Officer & Corporate Secretary |
| 4 | Mr. John Ruesch | Chief Technical Operations Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Deerfield Management Co | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | TCG Crossover Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 10 | Perceptive Advisors LLC | 0,00% | 0,00 Mio. USD |
| 11 | Vestal Point Capital LP | 0,00% | 0,00 Mio. USD |
| 12 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 13 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Kynam Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 15 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 16 | Aberdeen Group PLC | 0,00% | 0,00 Mio. USD |
| 17 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 18 | Two Sigma Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 20 | Royalty Pharma Sub-Manager, LLC | 0,00% | 0,00 Mio. USD |